in a group of 39 patients who received fibrinolytic therapy for acute myocardial infarction , serum crosslinked fibrin degradation products ( xldp ) were quantitated by an enzyme-linked immunosorbent assay ( elisa ) using an antibody reactive with a site near the gamma gamma crosslink of fibrin , and characterized by a gel electrophoretic method to distinguish fibrinogen degradation products ( fdp ) from xldp .
C0015982
fibrin
C0163275
fibrinogen degradation products